Literature DB >> 19010176

Correlation between beta-adrenoceptors and G-protein-coupled receptor kinases in pretransplantation heart failure.

J Agüero1, L Almenar, P D'Ocon, E Oliver, F Montó, J Moro, A Castelló, J Rueda, L Martínez-Dolz, I Sánchez-Lazaro, J A Montero.   

Abstract

INTRODUCTION: Prolonged catecholamine overstimulation of the myocardium in chronic heart failure causes a reduction in the number and functionality of beta1-adrenoceptors (beta1-AR) of the heart. Desensitization of beta1-AR is mediated by their phosphorylation by a group of cytosolic kinases (G-protein-coupled receptor kinases GRK). In advanced heart failure, an increase in GRK levels associated with the severity of the disease has been observed.
OBJECTIVE: The objective of this study was to analyze messenger RNA (mRNA) levels of beta1-AR in the myocardium of patients who underwent transplantation for advanced heart failure and their correlation with expression of the major cardiac isoenzymes of GRK.
MATERIALS AND METHODS: Myocardial tissue samples were obtained from the left ventricles of 14 explanted hearts of patients who underwent transplantation for dilated (n = 7) and ischemic (n = 7) cardiomyopathy. RT-PCR techniques were used to analyze mRNA levels of beta1-AR and the isoenzymes GRK2, GRK3, and GRK5.
RESULTS: We observed a significant correlation between beta1-AR and the 3 subtypes of GRK (R(2) = 0.668, 0.71, and 0.318, respectively).
CONCLUSIONS: In patients with advanced heart failure pretransplantation, we observed a significant correlation between beta1-AR and GRK2 and GRK3 levels. GRK5, the subtype predominantly expressed in the myocardium, showed a lesser correlation with beta1-AR levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010176     DOI: 10.1016/j.transproceed.2008.09.011

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

Review 1.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  "Canonical and non-canonical actions of GRK5 in the heart".

Authors:  Christopher J Traynham; Jonathan Hullmann; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2016-01-29       Impact factor: 5.000

3.  Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available.

Authors:  Kozo Hayashi; Ryo Yamashita; Ritsuko Takami; Toshikatsu Matsui; Masamitsu Gotou; Tomoyuki Nishimoto; Hiroyuki Kobayashi
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-08

4.  β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation.

Authors:  María Rodriguez-Serrano; Joaquín Rueda; Francisco Buendía; Fermi Monto; Jaime Aguero; Ana Osa; Oscar Cano; Luis Martínez-Dolz; Pilar D'Ocon
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.